Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+27.79%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$7.1B
AUM Growth
+$4.71B
(+197%)
Cap. Flow
+$3.99B
Cap. Flow
% of AUM
56.24%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
1,020
New
424
Increased
501
Reduced
44
Closed
50
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$577M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$492M |
| 3 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$178M |
| 4 |
Microsoft
MSFT
|
+$139M |
| 5 |
Apple
AAPL
|
+$132M |
Top Sells
| 1 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$312M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$136M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$31.7M |
| 4 |
Idexx Laboratories
IDXX
|
+$4.16M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$3.61M |
Sector Composition
| 1 | Technology | 24.57% |
| 2 | Financials | 13.35% |
| 3 | Energy | 3.93% |
| 4 | Healthcare | 3.4% |
| 5 | Real Estate | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOGM
651
DELISTED
LogMein, Inc.
LOGM
| $641K | 0.01% |
+7,565
| New | +$641K |
|
|
PTLA
652
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $640K | 0.01% |
35,586
+25,185
| +242% | +$453K |
|
653
Kodiak Sciences
KOD
$517M
| $638K | 0.01% |
+11,786
| New | +$638K |
|
654
Rithm Capital
RITM
$6.63B
| $634K | 0.01% |
85,276
+70,781
| +488% | +$526K |
|
655
DaVita
DVA
$9.62B
| $631K | 0.01% |
+7,971
| New | +$631K |
|
656
Xencor
XNCR
$600M
| $631K | 0.01% |
+19,466
| New | +$631K |
|
657
Consolidated Edison
ED
$34.9B
| $627K | 0.01% |
8,723
+3,051
| +54% | +$219K |
|
658
Morningstar
MORN
$10.9B
| $627K | 0.01% |
+4,451
| New | +$627K |
|
|
WORK
659
DELISTED
Slack Technologies, Inc.
WORK
| $627K | 0.01% |
+20,175
| New | +$627K |
|
660
Hancock Whitney
HWC
$5.33B
| $624K | 0.01% |
+29,451
| New | +$624K |
|
661
3M
MMM
$82B
| $624K | 0.01% |
4,786
+1,028
| +27% | +$134K |
|
662
Interactive Brokers
IBKR
$27.2B
| $620K | 0.01% |
+59,372
| New | +$620K |
|
663
Packaging Corp of America
PKG
$19.4B
| $619K | 0.01% |
+6,198
| New | +$619K |
|
664
EPR Properties
EPR
$4.05B
| $616K | 0.01% |
+18,583
| New | +$616K |
|
665
Charles River Laboratories
CRL
$7.97B
| $612K | 0.01% |
+3,510
| New | +$612K |
|
|
ICPT
666
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $609K | 0.01% |
12,704
+8,846
| +229% | +$424K |
|
667
Myriad Genetics
MYGN
$643M
| $601K | 0.01% |
53,038
+42,940
| +425% | +$487K |
|
668
Kirby Corp
KEX
$4.98B
| $599K | 0.01% |
+11,176
| New | +$599K |
|
|
GAP
669
The Gap, Inc.
GAP
$8.96B
| $599K | 0.01% |
+47,432
| New | +$599K |
|
|
EPZM
670
DELISTED
Epizyme, Inc
EPZM
| $598K | 0.01% |
+37,234
| New | +$598K |
|
671
CVB Financial
CVBF
$2.78B
| $597K | 0.01% |
+31,851
| New | +$597K |
|
672
Lazard
LAZ
$5.3B
| $594K | 0.01% |
+20,757
| New | +$594K |
|
673
Cadence Bank
CADE
$7.04B
| $593K | 0.01% |
+26,094
| New | +$593K |
|
674
Upland Software
UPLD
$67.6M
| $592K | 0.01% |
+17,037
| New | +$592K |
|
675
Akebia Therapeutics
AKBA
$830M
| $582K | 0.01% |
+42,874
| New | +$582K |
|